Intuitive Surgical, Inc. $ISRG Shares Sold by E. Ohman J or Asset Management AB

E. Ohman J or Asset Management AB cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,680 shares of the medical equipment provider’s stock after selling 4,626 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in Intuitive Surgical were worth $13,411,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Legacy Wealth Asset Management LLC increased its holdings in shares of Intuitive Surgical by 1.6% in the fourth quarter. Legacy Wealth Asset Management LLC now owns 2,921 shares of the medical equipment provider’s stock valued at $1,654,000 after purchasing an additional 45 shares during the period. Avanza Fonder AB raised its position in Intuitive Surgical by 0.5% during the 4th quarter. Avanza Fonder AB now owns 41,241 shares of the medical equipment provider’s stock worth $23,357,000 after buying an additional 191 shares during the last quarter. Salem Investment Counselors Inc. raised its position in Intuitive Surgical by 1.1% during the 4th quarter. Salem Investment Counselors Inc. now owns 61,958 shares of the medical equipment provider’s stock worth $35,091,000 after buying an additional 659 shares during the last quarter. Sunflower Bank N.A. lifted its stake in Intuitive Surgical by 4.2% during the 4th quarter. Sunflower Bank N.A. now owns 738 shares of the medical equipment provider’s stock valued at $418,000 after acquiring an additional 30 shares during the period. Finally, Capital Asset Advisory Services LLC boosted its holdings in shares of Intuitive Surgical by 1.3% in the 4th quarter. Capital Asset Advisory Services LLC now owns 8,045 shares of the medical equipment provider’s stock valued at $4,769,000 after acquiring an additional 104 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.0%

NASDAQ:ISRG opened at $478.04 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $603.88. The stock’s 50-day moving average price is $500.94 and its 200-day moving average price is $513.62. The stock has a market capitalization of $169.77 billion, a PE ratio of 60.59, a price-to-earnings-growth ratio of 3.69 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.21 EPS. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, VP Fredrik Widman sold 133 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the transaction, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. This represents a 16.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 32,943 shares of company stock worth $17,279,568. 0.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research reports. TD Cowen upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. HSBC upped their price target on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a report on Monday, January 26th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Sanford C. Bernstein boosted their price objective on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Finally, Robert W. Baird dropped their target price on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $614.95.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.